Revision: Dec. 23, 2019, 5:08 p.m.
SB 522 - AS INTRODUCED
2020 SESSION
20-2913
10/01
SENATE BILL 522
AN ACT requiring providers to get a verbal acknowledgment for an initial prescription for opioids.
SPONSORS: Sen. Bradley, Dist 3; Sen. Ward, Dist 8; Sen. Levesque, Dist 12; Sen. Hennessey, Dist 5; Sen. Reagan, Dist 17; Sen. Birdsell, Dist 19; Sen. Carson, Dist 14; Sen. Sherman, Dist 24; Rep. Hennessey, Graf. 1; Rep. Marsh, Carr. 8; Rep. Knirk, Carr. 3
COMMITTEE: Health and Human Services
-----------------------------------------------------------------
ANALYSIS
This bill requires a health care provider or pharmacy dispensing an initial prescription for an opioid to receive a verbal acknowledgment from the patient of the risk of addiction and overdose.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
20-2913
10/01
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Twenty
AN ACT requiring providers to get a verbal acknowledgment for an initial prescription for opioids.
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 Controlled Drugs Containing Opiates; Warnings Required. Amend RSA 318-B:16-a to read as follows:
318-B:16-a Controlled Drugs Containing Opiates; Warning Label and Verbal Acknowledgment Required. Any controlled drug containing opiates dispensed by a health care provider or pharmacy shall have an orange sticker with the word "opioid" in easily legible font placed on the cap or dispenser and shall have a warning label stating "Risk of addiction and overdose." The health care provider or pharmacist shall also provide each person with a handout which shall be developed and approved by the governor's commission on alcohol and drug abuse, prevention, treatment, and recovery which shall include guidance on associated risks of opioid use and how to mitigate them. Prior to an initial dispensing under a prescription, the health care provider or pharmacy shall receive a verbal acknowledgment from the patient of the risk of addiction and overdose for opioids. This section shall not apply to pharmacists or a pharmacy that dispenses a drug containing an opioid that is administered to a patient treated in a health care facility required to be licensed under RSA 151. A patient may remove the cap sticker or warning label.
2 Effective Date. This act shall take effect 60 days after its passage.